background image

ASX 200 gives tick of approval to fiscal stimulus extensions

Equities 5 minutes to read

Summary:  After a lacklustre start to the week, Asia is firmly risk on, following a strong lead from Wall Street overnight, where dip buyers piled into mega cap tech stocks leading US indices higher. The anticipation of a deal on the European recovery package alongside promising COVID-19 vaccine developments helped buoy sentiment overnight. In Australia, the ASX 200 giving the tick of approval to fiscal stimulus extensions. Technical breakouts on both the S&P and Nasdaq, alongside declining volatility which draws systematic buying paves the way for continued upside in the week ahead.


Last week’s tactical addition of more cyclical/value exposure relative to growth/momentum played well, with value factors across US indices outperforming momentum factors and the Russell 2000 and Dow outperforming the Nasdaq and tech heavy S&P. In Australia, value and cyclical factors also outperformed, with momentum underperforming as tech stocks and the bubbly “buy now, pay later” stocks came under pressure. The question now with the Nasdaq staging a clear break out overnight, albeit on significantly reduced breadth, whether to maintain the tactical increase in cyclical exposure?

The global COVID-19 case count continues to rise and return to “normal” becomes ever distant, economies remain on life support with ongoing central bank liquidity injections, bond buying and fiscal assistance the norm. With this, evidence is mounting that permanent job losses are stacking up, consumer caution is creeping higher as the virus has remained rampant into Q3, and the road to global recovery is emerging as long and winding. The speed of the rebounding data we have seen to date is unlikely to be maintained as recovery curves flatten, consistent with slowly plateauing recoveries fizzling out beyond the initial bounce back. However, this does not matter to financial markets at present, with risk asset pricing having detached from the real economy. A reminder that momentum and liquidity, alongside fiscal support, remain big drivers of the broad-based melt up in risk assets off the March lows. The support from central banks, ready and willing to act as and when is necessary, immunising financial markets against the fundamentals of the real economy. Incipient bubble or not, central banks have pledged ongoing support and liquidity, thus detaching asset prices from fundamentals and green lighting the hunt for yield. A dangerous dynamic in the long run, but not today’s focus. 

Plateauing recoveries, virus uncertainties and liquidity driven markets with a highly speculative flavour continues to support the allocation toward positive momentum trades – mega-cap technology, communications, software, growth and earnings duration. Multiple expansion remains a key driver of continued upside, with the low interest rate environment and lack of alternatives providing a premium for the high forecast future cash flows.

However, the growth factor trades at an extreme premium, with expectations running high as Q2 earnings kick up a notch in the US this week. Although this premium reflects a greater ability to capitalise off the COVID-19 acceleration of trends toward cloud computing, Saas, wfh, digitisation, and e-commerce, leaving these companies well positioned for the post-pandemic world. Essentially meaning “value” can be found in growth. There is a highly speculative portion of the recent advance in these stocks that may be due for a breather, unless the companies can meet and beat the lofty expectations embedded. Consequently, a temporary pause within a rising trend. Although we believe the companies leveraged toward these secular growth thematics will outperform in the medium/long run, valuations and excessively one sided positioning make us tactically cautious with respect to entry or increasing allocations at present.

The inability for the real economy to recover with the persistently rising virus case count globally and the threat of true second COVID-19 waves, as opposed to uncontrolled first waves once colder weather returns in the Northern Hemisphere keeps business investment and consumer sentiment capped. The nascent economic recovery is marred by the realisation that living with the virus is the new normal as many US states pause reopening, in Australia Melbourne locks down once again and NSW remains on high alert, with permanent job losses mounting and confidence dropping off. These factors being key deterrents to reflation trades and a broad based rotation into more economy dependant cyclicals. Without this value>growth remains nothing more than a tactical trade at present. Cyclical sectors will continue to trade at a discount, and the capacity for beaten down stocks and sectors to re-rate fully without the participation of the real economy is limited. Although there is scope for individual outperformance at the company level if companies meet lowered earnings estimates, given positioning is low. Investors will have to become more selective with respect to stock picking as the patchy recovery and post pandemic changes shape new investment paradigms.

Outside of equities, precious metals continue to perform, upholding the case for their place within a diversified portfolio. Silver remaining of interest as we flagged in early May, breaking through resistance at $19.65, the 2019 high, clearing the path to take aim at the 2016 highs. The gold/silver ratio continues to move lower as silver capitalises on a weaker dollar, industrial metal complex upside, and the positive momentum in gold. Gold is also shooting higher making fresh highs for the year. The monetization of deficits, debasement of fiat currency, low rates and YCC speculation, as real yields continue their march lower reduce the opportunity cost of holding gold, propelling the metal higher. As well, virus uncertainties compounding macro-economic unknowns and geopolitical risks continue to provide additional momentum for gold demand, with fresh all-time highs on the cards, likely by year-end. Beyond new all-time highs, a run at $2,000, an important psychological level, should be the next hurdle.

Australia Focus

In Australia, as expected the JobKeeper and JobSeeker payments have been extended at a lower rate for another six months. The scars of the global pandemic that leave realities of persistently high unemployment with permanent job losses mounting, prolonged social distancing measures and other restrictions impinging business margins, and resounding uncertainties that weigh on business and consumer confidence are yet to be felt. The extension of these support measures is critical in avoiding the harmful “fiscal cliff” effect that was due in September, particularly with Melbourne in lockdown and NSW cases rising, which has dampened consumer confidence once more, a critical driver of recovery. The ABS Payrolls data is consistent with the rebound in jobs plateauing and the labour market remaining depressed. To date the jobs recovered have been largely part-time and reflective of industries like hospitality and retail rebounding post lockdown. High frequency data is beginning to reflect the impact of fresh lockdowns in Melbourne that will drag on the recovery. Google/Apple mobility data, restaurant bookings, footfall, credit card spending, and new job postings are all dropping off or stalling. Despite the true unemployment rate being higher than outlined in the monthly jobs data, discretionary spending has remained supported by the government’s stimulus payments and early access to superannuation, which has insulated the Australian economy from some of the more dire predictions that emerged in February/March. Combined reflective of the ongoing need for the fiscal support measures as the economy sits on the precipice of the COVID-19 induced recession and a considerable degree of uncertainty remains. Particularly as the boost from the early access to superannuation fizzles, in some ways a wild card given the impact on discretionary spending is difficult to forecast.

Governor Lowe, speaking today, also reiterated the need for ongoing fiscal support for the Australian economy. With the transmission of monetary policy now somewhat limited when it comes to reinvigorating economic growth, the baton must be passed to fiscal support. Utilising Australia’s balance sheet capacity in reviving investment, productivity and confidence, alongside returning the labour market to potential. The cost of borrowing at the effective lower bound is not a hindrance to businesses or consumers, the uncertainties surrounding the economy and the virus are the primary issues. To which the answer is fiscal, with monetary policy playing second fiddle.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.